Eisai Co., Ltd. ( ESALF) - Key Metrics
ESALF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $825.27 | $64.25 | -$9.11 | -$24.11 |
| 2025Q4 | $733.34 | -$11.60 | $14.61 | -$3.39 |
| 2025Q3 | $780.28 | $60.94 | $124.02 | $112.24 |
| 2025Q2 | $709.58 | $36.51 | $76.15 | $67.28 |
| 2026Q1 | $722.38 | $51.60 | $3.90 | -$12.26 |
ESALF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 123.72% | 15.73 |
| 2025Q4 | 0% | -102.61 |
| 2025Q3 | 131.38% | 19.13 |
| 2025Q2 | 0% | 34.92 |
| 2026Q1 | 155.92% | 20.29 |
ESALF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.59% | 1.96% |
| 2025Q4 | -0.07% | 0% |
| 2025Q3 | 2.41% | 1.72% |
| 2025Q2 | 1.32% | 0% |
| 2026Q1 | -0.29% | 1.91% |
ESALF
Price: $30.61
Dividend Yield: 3.37%
Forward Dividend Yield: 3.34%
Payout Ratio: 132.31%
Dividend Per Share: 1.02 USD
Earnings Per Share: 0.87 USD
P/E Ratio: 33
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Market Capitalization: 8.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 40
DGR3: 8.90%
DGR5: 3.87%
DGR10: 3.25%
DGR20: 7.31%